The transgenic core will provide injection services for the construction of transgenic mice by injection of DNA into fertilized oocytes and mice carrying targeted mutations by injection of ES cells into mouse blastocysts. It will also provide Center members with promoter/enhancer constructs for directing gene expression to different parts of the GI tract that have been developed in Dr. Gordon's laboratory. It will also provide consultations on embryonic stem cell manipulations. Established embryonic stem cell lines and fibroblast feeder cells will be supplied by an existing separate facility, Dr. Ley's stem cell core (Cancer Center), which will do the transfection and expansion of ES cells. This stem cell core does not provide injection services. The proposed facility will be developed from a mini-facility now operated by the Ornitz and Gordon laboratories. These laboratories have had a high level of success deriving transgenic, chimeric transgenic and knockout mice, so it is predicted that the facility will be efficient. The Transgenic Mouse and Stem Cell Core is located in a mouse barrier facility across the street from the medical center. There appears to be ample space for both the injection stations and no limitation on space for housing mice. The Core is equipped with three injection stations. Upon receiving funding, trained technicians from the Gordon and Orvitz laboratories will be recruited to work full time for the Core, with both technicians responsible for microinjections and animal husbandry.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK052574-03
Application #
6564313
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$180,000
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Gathungu, Grace; Zhang, Yuanhao; Tian, Xinyu et al. (2018) Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease. World J Gastroenterol 24:623-630
Feng, Jing; Luo, Jialie; Yang, Pu et al. (2018) Piezo2 channel-Merkel cell signaling modulates the conversion of touch to itch. Science 360:530-533
Eberth, Jan M; Josey, Michele J; Mobley, Lee R et al. (2018) Who Performs Colonoscopy? Workforce Trends Over Space and Time. J Rural Health 34:138-147
Zhang, Daoxiang; Li, Lin; Jiang, Hongmei et al. (2018) Tumor-Stroma IL1?-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer. Cancer Res 78:1700-1712
Sullender, Meagan E; Baldridge, Megan T (2018) Norovirus interactions with the commensal microbiota. PLoS Pathog 14:e1007183
Brenot, Audrey; Knolhoff, Brett L; DeNardo, David G et al. (2018) SNAIL1 action in tumor cells influences macrophage polarization and metastasis in breast cancer through altered GM-CSF secretion. Oncogenesis 7:32
Luo, Jialie; Feng, Jing; Yu, Guang et al. (2018) Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch. J Allergy Clin Immunol 141:608-619.e7
Tarr, Gillian A M; Oltean, Hanna N; Phipps, Amanda I et al. (2018) Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition. Int J Med Microbiol 308:921-926
Baumann-Dudenhoeffer, Aimee M; D'Souza, Alaric W; Tarr, Phillip I et al. (2018) Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes. Nat Med 24:1822-1829
Kumar, Pardeep; Kuhlmann, F Matthew; Chakraborty, Subhra et al. (2018) Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity. J Clin Invest 128:3298-3311

Showing the most recent 10 out of 899 publications